Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources
Printer-friendly versionEmail this page to a friend

Stereotactic radiosurgery

Stereotactic radiosurgery is a form of radiation therapy that focuses high-powered x-rays on a small area of the body. With regular radiation therapy treatment, healthy tissue that is nearby also receives radiation. Stereotactic radiosurgery better focuses the radiation on the abnormal area.

Despite its name, it is considered a form of radiation therapy, not a surgical procedure.

Description

During treatment, you will lie on a table, which slides into a machine that delivers radiation beams. The machine may rotate around you while it works.

Sometimes, a head frame may be attached to your scalp to keep you very still during therapy. There are different machines used to perform stereotactic radiosurgery. Some require the use of a frame, and others do not.

At other times, a special plastic mask fitted for your face may be used.

The entire procedure, including the planning stage, takes about half a day or less. The time period when you are receiving the radiation is usually only about 30 minutes. Some patients receive therapy more than once.

Why the Procedure is Performed

It is often used to slow down the growth of small, deep brain tumors that are hard to remove during surgery. Such therapy may also be used in patients who are unable to have surgery, such as the elderly or those who are very sick. Radiosurgery may also be used after surgery to treat any remaining abnormal tissue.

Stereotactic radiosurgery was once limited to brain tumors, but today it may be used to treat other diseases and conditions, including:

Risks

Radiosurgery may damage tissue around the area being treated. Brain swelling may occur in people who received treatment to the brain. Swelling usually goes away, but some people may need medicine to control long-term swelling.

Before the Procedure

Before the treatment, you will have MRI or CT scans. Using these images, a computer creates a 3-D (three dimensional) map of the tumor area. This planning process helps your neurosurgeon and radiation oncologist to determine the specific treatment area.

The day before your procedure:

The day of your procedure:

After the Procedure

Often, you will be able to go home about an hour after the treatment is finished. You should arrange for someone to drive you home. Most people go back to their regular activities the next day, if there are no complications such as swelling. Some patients are kept in the hospital overnight for monitoring.

Outlook (Prognosis)

The effects of radiosurgery may take weeks or months to be seen. The prognosis depends on the condition being treated. Many times, your health care provider will monitor your progress using imaging tests such as MRI and CT scans.

Alternative Names

Gamma knife; Cyberknife; Stereotactic radiotherapy; Fractionated stereotactic radiotherapy; Cyclotrons; Linear accelerator; Lineacs; Proton beam radiosurgery

References

DeAngelis LM. Tumors of the Central Nervous System and Intracranial Hypertension and Hypotension. In: Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier;2007:chap 199.

Kavanagh BD, Timmerman RD. Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. Hematol Oncol Clin North Am. 2006;20:87-95.

Romanelli P, Anschel DJ. Radiosurgery for epilepsy. Lancet Neurol. 2006;5:613-620.

Sneed PK, Kased N, Huang K, Rubenstein JL. Brain metastases and neoplastic meningitis. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 52.

Zivin JA. Hemorrhagic Cerbrovascular Disease. In: Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier;2007:chap 432.

Update Date: 1/22/2009

Updated by: Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.


A.D.A.M. Logo